News

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...
FDA clears Moderna’s RSV vaccine for use in people ages 18 to 59
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
FDA expands approval of Moderna's RSV vaccine to some adults under age 60
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
BioPharma Dive1d
Moderna wins FDA OK to widen use of RSV vaccine
The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
Morningstar2mon
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
today announced that data from the Company’s Phase 2a human challenge study of EDP-323 in healthy adults infected with respiratory syncytial virus (RSV) has been accepted for an oral ...
Fox News2mon
After Val Kilmer’s pneumonia death, what to know about the respiratory virus
Viral pneumonia can sometimes stem from viruses that include the flu, common cold, COVID-19 and respiratory syncytial virus (RSV), according to Cleveland Clinic. This type of pneumonia typically ...
Medscape2mon
New Respiratory Syncytial Virus Vaccine Shows Strong Protection in Veterans
A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates ... funded in part by the US Department of Health and Human Services Biomedical Advanced Research and ...
PharmiWeb4mon
Shionogi Announces Positive Results from Phase 2 Human Challenge Trial of Respiratory Syncytial Virus (RSV) Oral Antiviral Candidate S-337395
Statistically Significant Reduction in Viral Load Confirmed in Clinical Trial Primary Endpoint Achieved In the highest dose group, there was an 88.94% reduction in viral load (P<0.0001) OSAKA, Japan, ...
CBS News5mon
What is the HMPV virus in China? The human metapneumovirus and its symptoms, explained.
The human metapneumovirus ... in 2001 and is part of the Pneumoviridae family along with respiratory syncytial virus, or RSV, according to the CDC. It may have been circulating even earlier ...
The Independent6mon
RSV: What are the symptoms of Respiratory Syncytial Virus as cases rise?
It all felt a bit surreal.” open image in gallery Electron microscope shows human respiratory syncytial virus (RSV) virions, colourised blue, and anti-RSV F protein/gold antibodies, colourised ...
Everyday Health6mon
RSV Vaccine: What You Need to Know
The RSV vaccine protects against RSV (respiratory syncytial virus), a common ... which allows the virus to attach to human cells. With this knowledge, scientists were able to develop a vaccine ...